Home > Financial Ratios > BETA DRUGS

BETA DRUGS
Fixed Capital/Sales

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.450.350.350.400.39

What is the latest Fixed Capital/Sales ratio of BETA DRUGS ?

The latest Fixed Capital/Sales ratio of BETA DRUGS is 0.45 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.45
Mar20250.35
Mar20240.35
Mar20230.40
Mar20220.39

How is Fixed Capital/Sales of BETA DRUGS Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.45
28.57
Mar2025 0.35
0.00
Mar2024 0.35
-12.50
Mar2023 0.4
2.56
Mar2022 0.39 -

Other Financial Ratios of BETA DRUGS


Compare Fixed Capital/Sales ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹1,996.2 Cr -9.1% -12.9% 2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-9.1%

-12.9%

2.8%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses